Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K E Weber

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Natural Resources Forum|May 1, 1994
Issues in natural resources management in developing countriesG B Thapa, K E Weber
Experimental Cell Research|July 1, 1980
Timing of endoreduplication induced by colcemid or radiation in BUdR-labeled human lymphocytesK E Weber, S F Hoegerman
The Journal of Experimental Biology|January 7, 1998
Aerial performance of Drosophila melanogaster from populations selected for upwind flight abilityJ H Marden, M R Wolf, K E Weber
Journal of Neurology|March 15, 2005
Recurrent spontaneous "neuroleptic malignant syndrome" in the absence of neuroleptic medication in probable dementia with Lewy bodiesK E Weber, R A Linker, R Lorenz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2012
EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancerP Dubsky, M Filipits, R Jakesz, et al.
British Journal of Cancer|October 26, 2013
The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patientsP Dubsky, J C Brase, R Jakesz, et al.
Breast Cancer Research and Treatment|August 20, 2017
BRCA1-like profile is not significantly associated with survival benefit of non-myeloablative intensified chemotherapy in the GAIN randomized controlled trialA G J van Rossum, P C Schouten, K E Weber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2020
Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevoT Karn, C Denkert, K E Weber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 8, 2021
Reconstructing tumor history in breast cancer: signatures of mutational processes and response to neoadjuvant chemotherapy<sup>⋆</sup>C Denkert, M Untch, S Benz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2018
Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response-final results from GeparSixtoS Loibl, K E Weber, K M Timms, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Natural Resources Forum|May 1, 1994
Issues in natural resources management in developing countriesG B Thapa, K E Weber
Experimental Cell Research|July 1, 1980
Timing of endoreduplication induced by colcemid or radiation in BUdR-labeled human lymphocytesK E Weber, S F Hoegerman
The Journal of Experimental Biology|January 7, 1998
Aerial performance of Drosophila melanogaster from populations selected for upwind flight abilityJ H Marden, M R Wolf, K E Weber
Journal of Neurology|March 15, 2005
Recurrent spontaneous "neuroleptic malignant syndrome" in the absence of neuroleptic medication in probable dementia with Lewy bodiesK E Weber, R A Linker, R Lorenz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2012
EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancerP Dubsky, M Filipits, R Jakesz, et al.
British Journal of Cancer|October 26, 2013
The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patientsP Dubsky, J C Brase, R Jakesz, et al.
Breast Cancer Research and Treatment|August 20, 2017
BRCA1-like profile is not significantly associated with survival benefit of non-myeloablative intensified chemotherapy in the GAIN randomized controlled trialA G J van Rossum, P C Schouten, K E Weber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2020
Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevoT Karn, C Denkert, K E Weber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 8, 2021
Reconstructing tumor history in breast cancer: signatures of mutational processes and response to neoadjuvant chemotherapy<sup>⋆</sup>C Denkert, M Untch, S Benz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2018
Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response-final results from GeparSixtoS Loibl, K E Weber, K M Timms, et al.
Pageof 2